Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0.31%2.58B | -0.93%2.55B | 0.15%2.6B | 3.50%10.54B | 1.17%2.76B | 5.72%2.57B | 4.81%2.57B | 3.10%2.59B | 3.99%10.18B | 5.13%2.73B |
| Cost of revenue | -1.61%1.16B | -5.85%1.13B | -1.37%1.22B | 3.89%5.02B | 2.48%1.41B | 7.85%1.18B | 4.63%1.2B | 1.23%1.24B | 4.93%4.84B | 11.35%1.37B |
| Gross profit | 1.95%1.41B | 3.34%1.42B | 1.55%1.38B | 3.14%5.51B | -0.15%1.35B | 3.98%1.39B | 4.96%1.38B | 4.88%1.35B | 3.17%5.35B | -0.51%1.36B |
| Operating expense | -2.47%751M | -0.66%751M | 1.64%743M | -8.11%3.07B | -24.29%798M | -6.33%770M | 4.85%756M | 0.27%731M | 16.05%3.34B | 32.58%1.05B |
| Staff costs | -5.39%193M | 0.48%209M | -1.49%199M | -4.66%839M | 11.94%225M | -26.35%204M | 2.97%208M | 1.00%202M | 8.24%880M | -6.94%201M |
| Selling and administrative expenses | 4.65%45M | -12.77%41M | 7.69%42M | 8.59%177M | 26.32%48M | -2.27%43M | 9.30%47M | 2.63%39M | -13.76%163M | -26.92%38M |
| -Selling and marketing expense | 4.65%45M | -12.77%41M | 7.69%42M | 8.59%177M | 26.32%48M | -2.27%43M | 9.30%47M | 2.63%39M | -13.76%163M | -26.92%38M |
| Depreciation and amortization | 1.13%448M | 1.59%446M | -1.56%441M | -6.46%1.78B | -26.11%450M | 2.55%443M | 1.86%439M | 3.94%448M | 10.58%1.9B | 30.97%609M |
| -Depreciation | 1.13%448M | 1.59%446M | -1.56%441M | -4.07%1.46B | -26.11%450M | 2.55%443M | 1.86%439M | 3.94%448M | 8.23%1.53B | 298.04%609M |
| -Amortization | ---- | ---- | ---- | -16.14%317M | ---- | ---- | ---- | ---- | 21.15%378M | ---- |
| Other operating expenses | 8.45%154M | 6.56%130M | 9.32%129M | -14.02%552M | -46.18%155M | 24.56%142M | 16.19%122M | -1.67%118M | 40.48%642M | 111.76%288M |
| Total other operating income | 43.55%89M | 25.00%75M | -10.53%68M | 12.55%278M | -2.44%80M | 37.78%62M | 0.00%60M | 26.67%76M | -17.94%247M | 10.81%82M |
| Operating profit | 7.47%662M | 8.23%671M | 1.44%632M | 21.91%2.44B | 84.39%555M | 20.55%616M | 5.08%620M | 10.85%623M | -12.95%2B | -46.91%301M |
| Net non-operating interest income (expenses) | 2.73%-107M | 1.79%-110M | 4.31%-111M | -0.23%-432M | 1.80%-109M | -1.85%-110M | 2.61%-112M | -3.57%-116M | -11.95%-431M | -24.72%-111M |
| Non-operating interest income | 0.00%8M | 57.14%11M | 22.22%11M | 25.93%34M | 11.11%10M | 60.00%8M | -12.50%7M | 80.00%9M | -10.00%27M | 0.00%9M |
| Non-operating interest expense | -2.54%115M | 1.68%121M | -2.40%122M | 1.77%461M | -0.83%119M | 4.42%118M | -3.25%119M | 6.84%125M | 10.49%453M | 29.03%120M |
| Total other finance cost | ---- | ---- | ---- | 0.00%5M | ---- | ---- | ---- | ---- | 0.00%5M | ---- |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | 0 | 0 | ||||||||
| Special income (charges) | 11.11%-24M | 2.63%-37M | 15.00%-34M | -3.88%-134M | -11.54%-29M | 15.63%-27M | -2.70%-38M | -17.65%-40M | -20.56%-129M | -18.18%-26M |
| Less:Write off | -11.11%24M | -2.63%37M | -15.00%34M | 3.88%134M | 11.54%29M | -15.63%27M | 2.70%38M | 17.65%40M | 20.56%129M | 18.18%26M |
| Other non-operating income (expenses) | 62.50%13M | 0.00%13M | 8.33%13M | -21.43%11M | -38.46%8M | -13.33%13M | -7.69%12M | 14M | ||
| Income before tax | 11.70%544M | 11.18%537M | 4.38%500M | 29.99%1.88B | 140.45%428M | 26.82%487M | 6.62%483M | 11.66%479M | -19.87%1.44B | -56.27%178M |
| Income tax | 9.09%132M | 9.45%139M | 2.38%129M | 6.42%481M | -12.30%107M | 24.74%121M | 2.42%127M | 15.60%126M | -30.57%452M | -30.29%122M |
| Net income | 12.57%412M | 11.80%398M | 5.10%371M | 40.73%1.4B | 473.21%321M | 27.53%366M | 8.21%356M | 10.31%353M | -13.81%992M | -75.86%56M |
| Net income continuous operations | 12.57%412M | 11.80%398M | 5.10%371M | 40.73%1.4B | 473.21%321M | 27.53%366M | 8.21%356M | 10.31%353M | -13.81%992M | -75.86%56M |
| Noncontrolling interests | 0 | 0.00%-1M | ||||||||
| Net income attributable to the company | 12.57%412M | 11.80%398M | 5.10%371M | 40.58%1.4B | 473.21%321M | 27.53%366M | 7.88%356M | 10.31%353M | -13.80%993M | -75.97%56M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 12.57%412M | 11.80%398M | 5.10%371M | 40.58%1.4B | 473.21%321M | 27.53%366M | 7.88%356M | 10.31%353M | -13.80%993M | -75.97%56M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 15.22%0.053 | 10.87%0.051 | 4.44%0.047 | 40.16%0.178 | 485.71%0.041 | 24.32%0.046 | 9.52%0.046 | 9.76%0.045 | -13.61%0.127 | -76.67%0.007 |
| Diluted earnings per share | 15.22%0.053 | 10.87%0.051 | 4.44%0.047 | 40.16%0.178 | 485.71%0.041 | 24.32%0.046 | 9.52%0.046 | 9.76%0.045 | -13.61%0.127 | -76.67%0.007 |
| Dividend per share | 0.00%0.04 | 0.00%0.04 | 25.00%0.05 | -5.88%0.16 | 0.00%0.04 | 0.00%0.04 | 0.00%0.04 | -20.00%0.04 | -10.53%0.17 | -20.00%0.04 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.